Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Dumping Syndrome

ClinicalTrials.gov lists 18 trials for Dumping Syndrome or a narrower condition beneath it.

MeSH D004377 Digestive System Diseases C06 C23
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 2 Phase 2 3 Phase 4 Phase 4 3 Not applicable Not applicable 10 Observational Observational 2 Phase 2 Phase 2 3 Phase 4 Phase 4 3 Not applicable Not applicable 10 Observational Observational 2

Trials per phase

18 of the 18 trials are tagged with Dumping Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Dumping Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Dumping Syndrome trials start? (11)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 2
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 4

2007: 1 trials (Phase 4 1) 2008: 2 trials (Phase 2 2) 2011: 1 trials (Not applicable 1) 2013: 2 trials (Phase 4 1, Phase 2 1) 2016: 1 trials (Observational 1) 2017: 4 trials (Not applicable 4) 2020: 1 trials (Not applicable 1) 2021: 2 trials (Not applicable 1, Phase 4 1) 2024: 2 trials (Not applicable 2) 2025: 1 trials (Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2025 1
2024 2
2021 2
2020 1
2017 4
2016 1
2013 2
2011 1
2008 2

No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Dumping Syndrome trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 2 3
Phase 4 3
Not applicable 10
Observational 2

How many Dumping Syndrome trials are recruiting? (5)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 3
Active, not recruiting 1
Completed 10
Terminated 1
Unknown status 3

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Dumping Syndrome trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Novartis Pharmaceuticals 1
RECORDATI GROUP 1

Which drugs are being tested for Dumping Syndrome? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Sulfasalazine 1

Interventions as named in the registry (12)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Pasireotide s.c. 3
Empagliflozine 1
Cabergoline Pill 1
Rifaximine 1
LAR Octreotide 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Dumping Syndrome trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Cholelithiasis 9 1
COVID-19 8 1
Cholecystitis 5 1
Hypoglycaemia 5 2
Cellulitis 4 1

Which publications cover Dumping Syndrome? (34)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
International consensus on the diagnosis and management of dumping syndrome. Nature reviews. Endocrinology 2020 Yes
Short-term outcomes of endoscopic gastro-jejunal revisions for treatment of dumping syndrome after Roux-En-Y gastric bypass. Surgical endoscopy 2020 Yes
Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obesity reviews : an official journal of the International Association for the Study of Obesity 2017 Yes
Surgery-related gastrointestinal symptoms in a prospective study of bariatric surgery patients: 3-year follow-up. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2017 Yes
Metabolic and nutritional complications of bariatric surgery : a review. Acta gastro-enterologica Belgica 2017 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages